中国卫生标准管理
中國衛生標準管理
중국위생표준관리
CHINA HEALTH STANDARD MANAGEMENT
2015年
18期
99-101
,共3页
邵珂%张卫丰%马海龙%刘锐%李长江
邵珂%張衛豐%馬海龍%劉銳%李長江
소가%장위봉%마해룡%류예%리장강
生长抑素%内镜%肝硬化%食管胃底%静脉曲张%出血
生長抑素%內鏡%肝硬化%食管胃底%靜脈麯張%齣血
생장억소%내경%간경화%식관위저%정맥곡장%출혈
Somatostatin%Endoscopy%Cirrhosis%Esophageal and gastric%Varices%Bleeding
目的 探讨分析生长抑素联合内镜治疗肝硬化并食管胃底静脉曲张破裂出血临床疗效.方法 随机抽取我院在2013年8月~2014年8月期间收治的90例肝硬化并食管胃底静脉曲张破裂出血患者,根据治疗方法的不同,将患者分为对照组和治疗组,每组45例,对照组采用生长抑素治疗,治疗组则采用生长抑素联合内镜治疗,对比两组患者的临床治疗效果.结果 治疗组患者止血成功率明显高于对照组,差异显著,有统计学意义(P < 0.05);随访6个月,治疗组静脉曲张消失率明显高于对照组,差异显著,有统计学意义(P < 0.05).结论 生长抑素联合内镜治疗肝硬化并食管胃底静脉曲张破裂出血,临床效果好.
目的 探討分析生長抑素聯閤內鏡治療肝硬化併食管胃底靜脈麯張破裂齣血臨床療效.方法 隨機抽取我院在2013年8月~2014年8月期間收治的90例肝硬化併食管胃底靜脈麯張破裂齣血患者,根據治療方法的不同,將患者分為對照組和治療組,每組45例,對照組採用生長抑素治療,治療組則採用生長抑素聯閤內鏡治療,對比兩組患者的臨床治療效果.結果 治療組患者止血成功率明顯高于對照組,差異顯著,有統計學意義(P < 0.05);隨訪6箇月,治療組靜脈麯張消失率明顯高于對照組,差異顯著,有統計學意義(P < 0.05).結論 生長抑素聯閤內鏡治療肝硬化併食管胃底靜脈麯張破裂齣血,臨床效果好.
목적 탐토분석생장억소연합내경치료간경화병식관위저정맥곡장파렬출혈림상료효.방법 수궤추취아원재2013년8월~2014년8월기간수치적90례간경화병식관위저정맥곡장파렬출혈환자,근거치료방법적불동,장환자분위대조조화치료조,매조45례,대조조채용생장억소치료,치료조칙채용생장억소연합내경치료,대비량조환자적림상치료효과.결과 치료조환자지혈성공솔명현고우대조조,차이현저,유통계학의의(P < 0.05);수방6개월,치료조정맥곡장소실솔명현고우대조조,차이현저,유통계학의의(P < 0.05).결론 생장억소연합내경치료간경화병식관위저정맥곡장파렬출혈,림상효과호.
Objective Discussion Analysis of somatostatin combined with endoscopic treatment of liver cirrhosis and esophageal varices bleeding clinical efficacy. Methods I randomly selected hospital in August 2013 ~ August 2014 period were treated 90 patients with liver cirrhosis and esophageal varices bleeding, depending on the method of treatment, the patients were divided into a control group and treatment group 45 patients in the control group received somatostatin treatment group is used somatostatin combined with endoscopic treatment, compared to the clinical treatment of the two groups of patients. Results The success rate of the treatment group was significantly higher in patients with bleeding, significant difference was statistically significant (P < 0.05); follow-up of six months, the treatment group was significantly higher varicose veins disappear, significant difference was statistically significant (P < 0.05).Conclusion Somatostatin combined with endoscopic treatment of liver cirrhosis and esophageal varices bleeding, good clinical effect.